US FDA approves Mesoblast's cell therapy for graft-versus-host disease
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast (NASDAQ: MESO )'s cell therapy for treating a type of complication that occurs after a stem cell or bo...
Micron's second-quarter forecast disappoints; shares tumble
(Reuters) -Micron Technology forecast second-quarter revenue and profit below Wall Street estimates on Wednesday, as weakened prices of memory chips used in handsets and PCs weigh on earnings, se...
Two Epic Games directors appointed by Tencent resign, US Justice Department says
By Kanishka Singh WASHINGTON (Reuters) -Two directors of Epic Games who had been appointed by Chinese gaming and social media firm Tencent Holdings (OTC: TCEHY ) resigned from th...
